Target Price | $380.37 |
Price | $334.37 |
Potential | 13.76% |
Number of Estimates | 35 |
35 Analysts have issued a price target Visa 2026 . The average Visa target price is $380.37. This is 13.76% higher than the current stock price. The highest price target is $410.00 22.62% , the lowest is $300.00 10.28% . | |
A rating was issued by 43 analysts: 32 Analysts recommend Visa to buy, 9 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 13.76% . Most analysts recommend the Visa stock at Purchase. |
34 Analysts have issued a sales forecast Visa 2025 . The average Visa sales estimate is $39.5b . This is 7.47% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $40.0b 8.80% , the lowest is $38.6b 5.00% .
This results in the following potential growth metrics:
2024 | $35.9b | 10.02% |
---|---|---|
2025 | $39.5b | 10.09% |
2026 | $43.6b | 10.15% |
2027 | $47.8b | 9.74% |
2028 | $52.0b | 8.80% |
27 Analysts have issued an Visa EBITDA forecast 2025. The average Visa EBITDA estimate is $27.9b . This is 8.19% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $28.9b 12.25% , the lowest is $27.1b 5.28% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $25.2b | 9.73% |
---|---|---|
2025 | $27.9b | 10.63% |
2026 | $30.8b | 10.51% |
2027 | $33.9b | 10.12% |
2028 | $36.6b | 7.97% |
2024 | 70.13% | 0.26% |
---|---|---|
2025 | 70.48% | 0.50% |
2026 | 70.71% | 0.33% |
2027 | 70.96% | 0.35% |
2028 | 70.42% | 0.76% |
24 Visa Analysts have issued a net profit forecast 2025. The average Visa net profit estimate is $21.7b . This is 13.40% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $22.2b 16.24% , the lowest is $20.6b 7.71% .
This results in the following potential growth metrics and future Net Margins:
2024 | $18.7b | 17.67% |
---|---|---|
2025 | $21.7b | 15.77% |
2026 | $24.7b | 14.03% |
2027 | $27.9b | 12.69% |
2028 | $30.7b | 9.95% |
2024 | 52.19% | 6.95% |
---|---|---|
2025 | 54.88% | 5.16% |
2026 | 56.81% | 3.52% |
2027 | 58.34% | 2.69% |
2028 | 58.96% | 1.06% |
24 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $11.10 . This is 13.38% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.38 16.24% , the lowest is $10.55 7.76% .
This results in the following potential growth metrics and future valuations:
2024 | $9.59 | 17.67% |
---|---|---|
2025 | $11.10 | 15.75% |
2026 | $12.66 | 14.05% |
2027 | $14.27 | 12.72% |
2028 | $15.69 | 9.95% |
Current | 34.16 | 8.31% |
---|---|---|
2025 | 30.12 | 11.83% |
2026 | 26.41 | 12.32% |
2027 | 23.44 | 11.25% |
2028 | 21.32 | 9.04% |
Based on analysts' sales estimates for 2025, the Visa stock is valued at an EV/Sales of 16.59 and an P/S ratio of 16.52 .
This results in the following potential growth metrics and future valuations:
Current | 17.83 | 9.52% |
---|---|---|
2025 | 16.59 | 6.93% |
2026 | 15.07 | 9.22% |
2027 | 13.73 | 8.87% |
2028 | 12.62 | 8.09% |
Current | 17.75 | 9.22% |
---|---|---|
2025 | 16.52 | 6.95% |
2026 | 14.99 | 9.22% |
2027 | 13.66 | 8.87% |
2028 | 12.56 | 8.09% |
Analyst | Rating | Action | Date |
---|---|---|---|
Evercore ISI Group |
➜
In-Line
|
Initiated | Apr 09 2025 |
Susquehanna |
Positive
➜
Positive
|
Unchanged | Feb 21 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 03 2025 |
B of A Securities |
Neutral
➜
Neutral
|
Unchanged | Jan 31 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jan 31 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Jan 31 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jan 31 2025 |
Analyst Rating | Date |
---|---|
Initiated
Evercore ISI Group:
➜
In-Line
|
Apr 09 2025 |
Unchanged
Susquehanna:
Positive
➜
Positive
|
Feb 21 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 03 2025 |
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
Jan 31 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jan 31 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Jan 31 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jan 31 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.